Cargando…

Serum Neurofilament Identifies Patients With Multiple Sclerosis With Severe Focal Axonal Damage in a 6-Year Longitudinal Cohort

BACKGROUND AND OBJECTIVES: Immunomodulatory therapies reduce the relapse rate but only marginally control disability progression in patients with MS. Although serum neurofilament light chain (sNfL) levels correlate best with acute signs of inflammation (e.g., relapses and gadolinium-enhancing [Gd+]...

Descripción completa

Detalles Bibliográficos
Autores principales:	Steffen, Falk, Uphaus, Timo, Ripfel, Nina, Fleischer, Vinzenz, Schraad, Muriel, Gonzalez-Escamilla, Gabriel, Engel, Sinah, Groppa, Sergiu, Zipp, Frauke, Bittner, Stefan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9679887/ https://www.ncbi.nlm.nih.gov/pubmed/36411080 http://dx.doi.org/10.1212/NXI.0000000000200055

Ejemplares similares

NfL predicts relapse-free progression in a longitudinal multiple sclerosis cohort study: Serum NfL predicts relapse-free progression
por: Uphaus, Timo, et al.
Publicado: (2021)

Serum neurofilament levels reflect outer retinal layer changes in multiple sclerosis
por: Seitz, Caspar B., et al.
Publicado: (2021)

Elevated neurofilament light chain CSF/serum ratio indicates impaired CSF outflow in idiopathic intracranial hypertension
por: Engel, Sinah, et al.
Publicado: (2023)

Association of intrathecal pleocytosis and IgG synthesis with axonal damage in early MS
por: Engel, Sinah, et al.
Publicado: (2020)

Improved prediction of early cognitive impairment in multiple sclerosis combining blood and imaging biomarkers
por: Brummer, Tobias, et al.
Publicado: (2022)

Predictors for insufficient SARS-CoV-2 vaccination response upon treatment in multiple sclerosis
por: Schraad, Muriel, et al.
Publicado: (2022)

Intrathecal B-cell accumulation and axonal damage distinguish MRI-based benign from aggressive onset in MS
por: Engel, Sinah, et al.
Publicado: (2019)

Implications of extreme serum neurofilament light chain levels for the management of patients with relapsing multiple sclerosis
por: Engel, Sinah, et al.
Publicado: (2021)

Spatial transcriptomics and neurofilament light chain reveal changes in lesion patterns in murine autoimmune neuroinflammation
por: Brummer, Tobias, et al.
Publicado: (2023)

Network alterations underlying anxiety symptoms in early multiple sclerosis
por: Ellwardt, Erik, et al.
Publicado: (2022)

Impact of Dietary Intervention on Serum Neurofilament Light Chain in Multiple Sclerosis
por: Bock, Markus, et al.
Publicado: (2021)

Association of serum neurofilament light chain levels and neuropsychiatric manifestations in systemic lupus erythematosus
por: Engel, Sinah, et al.
Publicado: (2021)

Supplementary medication in multiple sclerosis: Real-world experience and potential interference with neurofilament light chain measurement
por: Pape, Katrin, et al.
Publicado: (2020)

Continuous reorganization of cortical information flow in multiple sclerosis: A longitudinal fMRI effective connectivity study
por: Fleischer, Vinzenz, et al.
Publicado: (2020)

Structural Brain Network Characteristics Can Differentiate CIS from Early RRMS
por: Muthuraman, Muthuraman, et al.
Publicado: (2016)

Clinical implications of serum neurofilament in newly diagnosed MS patients: A longitudinal multicentre cohort study
por: Bittner, Stefan, et al.
Publicado: (2020)

Preventing disease progression in multiple sclerosis—insights from large real-world cohorts
por: Engel, Sinah, et al.
Publicado: (2022)

The potential of serum neurofilament as biomarker for multiple sclerosis
por: Bittner, Stefan, et al.
Publicado: (2021)

GFAPα IgG-associated encephalitis upon daclizumab treatment of MS
por: Luessi, Felix, et al.
Publicado: (2018)

Brain network correlates of epilepsy occurrence in multiple sclerosis and neuroinflammation
por: Ciolac, Dumitru, et al.
Publicado: (2022)

Longitudinal cortical network reorganization in early relapsing–remitting multiple sclerosis
por: Fleischer, Vinzenz, et al.
Publicado: (2019)

Covarying patterns of white matter lesions and cortical atrophy predict progression in early MS
por: Muthuraman, Muthuraman, et al.
Publicado: (2020)

A Case of Progressive Multifocal Leukoencephalopathy in a Fumaric Acid-Treated Psoriasis Patient With Severe Lymphopenia Among Other Risk Factors
por: Engel, Sinah, et al.
Publicado: (2021)

PPMS onset upon adalimumab treatment extends the spectrum of anti-TNF-α therapy-associated demyelinating disorders
por: Engel, Sinah, et al.
Publicado: (2020)

Linking Microstructural Integrity and Motor Cortex Excitability in Multiple Sclerosis
por: Radetz, Angela, et al.
Publicado: (2021)

Selective Brain Network and Cellular Responses Upon Dimethyl Fumarate Immunomodulation in Multiple Sclerosis
por: Ciolac, Dumitru, et al.
Publicado: (2019)

Changes in Neurofilament and Microtubule Distribution following Focal Axon Compression
por: Fournier, Adam J., et al.
Publicado: (2015)

Attenuation of immune activation in patients with multiple sclerosis on a wheat-reduced diet: a pilot crossover trial
por: Engel, Sinah, et al.
Publicado: (2023)

Gray matter integrity predicts white matter network reorganization in multiple sclerosis
por: Radetz, Angela, et al.
Publicado: (2019)

Choroid plexus imaging to track neuroinflammation – a translational model for mouse and human studies
por: Muthuraman, Muthuraman, et al.
Publicado: (2022)

Gray matter network reorganization in multiple sclerosis from 7‐Tesla and 3‐Tesla MRI data
por: Gonzalez‐Escamilla, Gabriel, et al.
Publicado: (2020)

Sex-specific signatures of intrinsic hippocampal networks and regional integrity underlying cognitive status in multiple sclerosis
por: Ciolac, Dumitru, et al.
Publicado: (2021)

Cardiotoxicity of Mitoxantrone Treatment in a German Cohort of 639 Multiple Sclerosis Patients
por: Fleischer, Vinzenz, et al.
Publicado: (2014)

Association Between Serum Levels of Neurofilament Light Chains and Minimal Hepatic Encephalopathy in Patients With Liver Cirrhosis
por: Labenz, Christian, et al.
Publicado: (2021)

Structural brain network fingerprints of focal dystonia
por: Chirumamilla, Venkata C., et al.
Publicado: (2019)

Comparative effectiveness of natalizumab versus ocrelizumab in multiple sclerosis: a real-world propensity score–matched study
por: Pape, Katrin, et al.
Publicado: (2022)

Phosphorylation and compactness of neurofilaments in multiple sclerosis: Indicators of axonal pathology()
por: Petzold, Axel, et al.
Publicado: (2008)

Neurofilament-dependent Radial Growth of Motor Axons and Axonal Organization of Neurofilaments Does Not Require the Neurofilament Heavy Subunit (NF-H) or Its Phosphorylation
por: Rao, Mala V., et al.
Publicado: (1998)

Control of axonal caliber by neurofilament transport
Publicado: (1984)

Neurofilament heavy chain side arm phosphorylation regulates axonal transport of neurofilaments
por: Ackerley, Steven, et al.
Publicado: (2003)

Cannot write session to /tmp/vufind_sessions/sess_dhj72s38h8341iommhjeoaseub